{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T03:15:40Z","timestamp":1787022940411,"version":"build-2736575974"},"reference-count":40,"publisher":"Akademiai Kiado Zrt.","issue":"2","content-domain":{"domain":["akjournals.com"],"crossmark-restriction":true},"short-container-title":["AMicr"],"published-print":{"date-parts":[[2025,6,20]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    <jats:italic>Stenotrophomonas maltophilia<\/jats:italic>\n                    is an opportunistic pathogen that can cause infections especially in hospital settings and in immunocompromised individuals. Due to its resistance to many broad-spectrum antibiotics, treatment options that can be used in clinical practice are limited. This study aims to evaluate the susceptibility profiles of\n                    <jats:italic>S. maltophilia<\/jats:italic>\n                    isolates to antimicrobial agents commonly used in treatment and to investigate the presence of different classes of integrons and\n                    <jats:italic>sul<\/jats:italic>\n                    genes responsible for resistance. The study included 100\u2009\n                    <jats:italic>S. maltophilia<\/jats:italic>\n                    isolates from various clinical samples sent to Bal\u0131kesir University Health Practice and Research Hospital Medical Microbiology Laboratory between 2017 and 2023. The BD Phoenix\u2122 M50 Automated System was used for bacterial identification and antibiotic sensitivity testing. The susceptibility of isolates to trimethoprim-sulfamethoxazole was also studied by disk diffusion method. All isolates were investigated for\n                    <jats:italic>sul1, sul2<\/jats:italic>\n                    genes and integron-associated integrase genes by polymerase chain reaction. The susceptibility rates of isolates to trimethoprim-sulfamethoxazole, levofloxacin and ceftazidime were determined as 96%, 66% and 38%, respectively. Polymerase chain reaction results showed,\n                    <jats:italic>intI1<\/jats:italic>\n                    and\n                    <jats:italic>sul1<\/jats:italic>\n                    genes were found to be positive together in two isolates resistant to trimethoprim-sulfamethoxazole, while\n                    <jats:italic>sul1<\/jats:italic>\n                    and\n                    <jats:italic>sul2<\/jats:italic>\n                    genes were found in two separate isolates sensitive to trimethoprim-sulfamethoxazole. The\n                    <jats:italic>intI2<\/jats:italic>\n                    gene was not detected in any isolate. This study addresses the clinically important problems of\n                    <jats:italic>S. maltophilia<\/jats:italic>\n                    infections, which are increasingly difficult to treat due to intrinsic and acquired resistance mechanisms. By providing valuable information on antimicrobial susceptibility and resistance profiles of\n                    <jats:italic>S. maltophilia<\/jats:italic>\n                    isolates, it contributes to national data and guides efforts to control resistance and promote rational antibiotic use.\n                  <\/jats:p>","DOI":"10.1556\/030.2025.02582","type":"journal-article","created":{"date-parts":[[2025,5,22]],"date-time":"2025-05-22T10:28:45Z","timestamp":1747909725000},"page":"139-144","update-policy":"https:\/\/doi.org\/10.1556\/policypage.crossmark.crossref.2","source":"Crossref","is-referenced-by-count":2,"title":["Retrospective analysis of antibiotic resistance profiles and frequency of resistance genes in clinical Stenotrophomonas maltophilia isolates"],"prefix":"10.1556","volume":"72","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3737-2663","authenticated-orcid":true,"given":"Nuref\u015fan","family":"Erdiren","sequence":"first","affiliation":[{"name":"Faculty of Medicine, Department of Medical Microbiology, Bal\u0131kesir University, Bal\u0131kesir, Turkey"},{"name":"Ali Osman S\u00f6nmez Oncology Hospital, Bursa, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2433-1977","authenticated-orcid":true,"given":"Tu\u011fba","family":"Kula Atik","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, Department of Medical Microbiology, Bal\u0131kesir University, Bal\u0131kesir, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"425","reference":[{"issue":"1","key":"B1","series-title":"Clin Microbiol Rev","first-page":"2","article-title":"Stenotrophomonas maltophilia: an emerging global opportunistic pathogen","volume":"25","author":"Brooke JS","year":"2021","unstructured":"Brooke JS. Stenotrophomonas maltophilia: an emerging global opportunistic pathogen. Clin Microbiol Rev 2021; 25(1): 2\u201341. https:\/\/doi.org\/10.1128\/CMR.00019-11."},{"issue":"3","key":"B2","series-title":"Clin Microbiol Rev","article-title":"Advances in themicrobiology of Stenotrophomonas maltophilia","volume":"34","author":"Brooke JS","year":"2021","unstructured":"Brooke JS. Advances in themicrobiology of Stenotrophomonas maltophilia. Clin Microbiol Rev 2021; 34(3): e0003019. https:\/\/doi.org\/10.1128\/CMR.00030-19."},{"key":"B3","series-title":"Bailey & Scott\u2019s Diagnostic Microbiology","first-page":"329","article-title":"Acinetobacter, Stenotrophomonas, and similar organisms","author":"Tille PM","year":"2014","unstructured":"Tille PM. Acinetobacter, Stenotrophomonas, and similar organisms. In: Bailey & Scott\u2019s Diagnostic Microbiology, 13th ed. Missouri: Elsevier; 2014. p. 329\u201334."},{"key":"B4","series-title":"Front Microbiol","first-page":"893","article-title":"Update on infections caused by Stenotrophomonas maltophilia with particular attention to resistance mechanisms and therapeutic options","volume":"6","author":"Chang YT","year":"2015","unstructured":"Chang YT, Lin CY, Chen YH, Hsueh PR. Update on infections caused by Stenotrophomonas maltophilia with particular attention to resistance mechanisms and therapeutic options. Front Microbiol 2015; 6: 893. https:\/\/doi.org\/10.3389\/fmicb.2015.00893."},{"issue":"2","key":"B5","series-title":"Int J Antimicrob Agents","first-page":"95","article-title":"Antimicrobial susceptibility of uncommonly isolated non-enteric Gram-negative bacilli","volume":"25","author":"Sader HS","year":"2005","unstructured":"Sader HS, Jones RN. Antimicrobial susceptibility of uncommonly isolated non-enteric Gram-negative bacilli. Int J Antimicrob Agents 2005; 25(2): 95\u2013109. https:\/\/doi.org\/10.1016\/j.ijantimicag.2004.10.002."},{"key":"B6","series-title":"Manual of clinical microbiology","first-page":"692","article-title":"Burkholderia, Stenotrophomonas, Ralstonia, Cupriavidus, Pandoraea, Brevundimonas, Comamonas, Delftia, and Acidovorax","author":"LiPuma J","year":"2011","unstructured":"LiPuma J, Currie B, Peacock S, Vandamme P. Burkholderia, Stenotrophomonas, Ralstonia, Cupriavidus, Pandoraea, Brevundimonas, Comamonas, Delftia, and Acidovorax. In: Versalovic J, Carroll K, Funke G, Jorgensen J, Landry M, Warnock D, editors. Manual of clinical microbiology, 10th ed. Washington, DC: ASM Press; 2011. p. 692\u2013713."},{"issue":"6","key":"B7","series-title":"J\u00a0Chemother","first-page":"297","article-title":"Antimicrobial treatment of Stenotrophomonas maltophilia invasive infections: systematic review","volume":"31","author":"An\u0111elkovi\u0107 MV","year":"2019","unstructured":"An\u0111elkovi\u0107 MV, Jankovi\u0107 SM, Kosti\u0107 MJ, \u017divkovi\u0107 Zari\u0107 RS, Opan\u010dina VD, \u017divi\u0107 M\u017d, et al. Antimicrobial treatment of Stenotrophomonas maltophilia invasive infections: systematic review. J\u00a0Chemother 2019; 31 (6): 297\u2013306. https:\/\/doi.org\/10.1080\/1120009X.2019.1620405."},{"key":"B8","series-title":"Rev Inst Med Trop Sao Paulo","first-page":"e96","article-title":"Clinical and microbiological characteristics of patients colonized or infected by Stenotrophomonas maltophilia : is resistance to sulfamethoxazole\/trimethoprim a problem?","volume":"62","author":"Mendes ET","year":"2020","unstructured":"Mendes ET, Paez JIG, Ferraz JR, Marchi AP, Silva ILAFE, Batista MV, et al. Clinical and microbiological characteristics of patients colonized or infected by Stenotrophomonas maltophilia : is resistance to sulfamethoxazole\/trimethoprim a problem? Rev Inst Med Trop Sao Paulo 2020; 62: e96. https:\/\/doi.org\/10.1590\/S1678-9946202062096."},{"key":"B9","article-title":"TMC-ADTS restricted notification tables","year":"2022","unstructured":"TMC-ADTS restricted notification tables; 2022. Access address: https:\/\/www.tmc-online.org . Date of access: 15.03.2023."},{"key":"B10","article-title":"European Committee on Antimicrobial Susceptibility Testing. Breakpoint tables for interpretation of MICs and zone diameters","unstructured":"European Committee on Antimicrobial Susceptibility Testing. Breakpoint tables for interpretation of MICs and zone diameters. Version 13.01.2023. https:\/\/www.eucast.org\/fileadmin\/src\/media\/PDFs\/EUCAST_files\/Breakpoint_tables\/v_13.1_Breakpoint_Tables.pdf."},{"key":"B11","series-title":"Performance standards for antimicrobial susceptibility testing","author":"Clinical and Laboratory Standards Institute","year":"2021","unstructured":"Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing, 31st ed.. CLSI Supplement M100. Clinical and Laboratory Standard Institute; 2021."},{"issue":"2","key":"B12","series-title":"J Microbiol Methods","first-page":"221","article-title":"Multiplex PCR for screening of integrons in bacterial lysates","volume":"62","author":"Dillon B","year":"2005","unstructured":"Dillon B, Thomas L, Mohmand G, Zelynski A, Iredell J. Multiplex PCR for screening of integrons in bacterial lysates. J Microbiol Methods 2005; 62(2): 221\u2013232. https:\/\/doi.org\/10.1016\/j.mimet.2005.02.007."},{"issue":"4","key":"B13","series-title":"J Antimicrob Chemother","first-page":"513","article-title":"Susceptibility of Danish Escherichia coli strains isolated from urinary tract infections and bacteraemia, and distribution of sul genes conferring sulphonamide resistance","volume":"50","author":"Kerrn MB","year":"2002","unstructured":"Kerrn MB, Klemmensen T, Frimodt-M\u00f8ller N, Espersen F. Susceptibility of Danish Escherichia coli strains isolated from urinary tract infections and bacteraemia, and distribution of sul genes conferring sulphonamide resistance. J Antimicrob Chemother 2002; 50(4): 513\u2013516. https:\/\/doi.org\/10.1093\/jac\/dkf164."},{"key":"B14","series-title":"Antimicrobial susceptibility and molecular epidemiology of clinical Stenotrophomonas maltophilia isolates, 2016","author":"Parkan \u00d6M","unstructured":"Parkan \u00d6M. Antimicrobial susceptibility and molecular epidemiology of clinical Stenotrophomonas maltophilia isolates, 2016 Thesis on specialization in Medicine. Erciyes University Faculty of Medicine, Department of Medical Microbiology. https:\/\/tez.yok.gov.tr\/UlusalTezMerkezi."},{"issue":"6","key":"B15","series-title":"J Antimicrob Chemother","first-page":"921","article-title":"Typing of 154 clinical isolates of Stenotrophomonas maltophilia by pulsed-field gel electrophoresis and determination of the in vitro susceptibilities of these strains to 28 antibiotics","volume":"45","author":"Schmitz FJ","year":"2000","unstructured":"Schmitz FJ, Sadurski R, Verhoef J, Milatovic D, Fluit AC. Typing of 154 clinical isolates of Stenotrophomonas maltophilia by pulsed-field gel electrophoresis and determination of the in vitro susceptibilities of these strains to 28 antibiotics. J Antimicrob Chemother 2000; 45(6): 921\u2013923. https:\/\/doi.org\/10.1093\/jac\/45.6.921."},{"issue":"2","key":"B16","series-title":"Eur J Microbiol Immunol (Bp)","first-page":"91","article-title":"A 10-year single-center experience on Stenotrophomonas maltophilia resistotyping in Szeged, Hungary","volume":"10","author":"Gajd\u00e1cs M","year":"2020","unstructured":"Gajd\u00e1cs M, Urb\u00e1n E. A 10-year single-center experience on Stenotrophomonas maltophilia resistotyping in Szeged, Hungary. Eur J Microbiol Immunol (Bp) 2020; 10(2): 91\u201397. https:\/\/doi.org\/10.1556\/1886.2020.00006."},{"issue":"1","key":"B17","series-title":"ANKEM J","first-page":"16","article-title":"Antibiotic susceptibility of Stenotrophomonas maltophilia strains isolated from various clinical samples","volume":"36","author":"Arabac\u0131 \u00c7","year":"2019","unstructured":"Arabac\u0131 \u00c7, Yan\u0131lmaz \u00d6, Uzun B. Antibiotic susceptibility of Stenotrophomonas maltophilia strains isolated from various clinical samples. ANKEM J 2019; 36(1): 16\u201322. https:\/\/doi.org\/10.5222\/ankem.2019.198."},{"issue":"2","key":"B18","series-title":"J Turkish Soc Microbiol","first-page":"75","article-title":"Distribution and antimicrobial susceptibility of Stenotrophomonas maltophilia strains isolated from various clinical samples\u00a0over five years","volume":"44","author":"G\u00fczelant A","year":"2014","unstructured":"G\u00fczelant A, Kaya M, G\u00fcven\u00e7 H\u0130, Akkaya O, Y\u00fcksekkaya \u015e, Opu\u015f A, et al. Distribution and antimicrobial susceptibility of Stenotrophomonas maltophilia strains isolated from various clinical samples\u00a0over five years. J Turkish Soc Microbiol 2014; 44(2): 75\u20139. https:\/\/doi.org\/10.5222\/TMCD.2014.075."},{"issue":"2","key":"B19","series-title":"J Turkish Soc Microbiol","first-page":"134","article-title":"Attention! There is a significant increase in trimethoprim-sulfamethoxazole and levofloxacin resistance of Stenotrophomanas maltophilia strains isolated from clinical samples (2008\u20132016)","volume":"48","author":"Haz\u0131rolan G","year":"2018","unstructured":"Haz\u0131rolan G, Araz H, \u00c7elikba\u015f AK, Aksu N. Attention! There is a significant increase in trimethoprim-sulfamethoxazole and levofloxacin resistance of Stenotrophomanas maltophilia strains isolated from clinical samples (2008\u20132016). J Turkish Soc Microbiol 2018; 48(2): 134\u2013140. https:\/\/doi.org\/10.5222\/TMCD.2018.134."},{"issue":"12","key":"B20","series-title":"J Clin Diagn Res","first-page":"DC20","article-title":"Stenotrophomonas maltophilia in lower respiratory tract infections","volume":"8","author":"Chawla K","year":"2014","unstructured":"Chawla K, Vishwanath S, Gupta A. Stenotrophomonas maltophilia in lower respiratory tract infections. J Clin Diagn Res 2014; 8(12): DC20\u2013DC22. https:\/\/doi.org\/10.7860\/JCDR\/2014\/10780.5320."},{"issue":"1","key":"B21","series-title":"Dicle Med J","first-page":"147","article-title":"Distribution and antimicrobial susceptibility of Stenotrophomonas maltophilia strains isolated from various clinical samples: an 8-year study","volume":"48","author":"Bah\u00e7eci \u0130","year":"2021","unstructured":"Bah\u00e7eci \u0130. Distribution and antimicrobial susceptibility of Stenotrophomonas maltophilia strains isolated from various clinical samples: an 8-year study. Dicle Med J 2021; 48(1): 147\u2013152. https:\/\/doi.org\/10.5798\/dicletip.887633."},{"issue":"Suppl 2","key":"B22","series-title":"Clin Infect Dis","first-page":"S104","article-title":"Emerging importance of multidrug-resistant Acinetobacter species and Stenotrophomonas maltophilia as pathogens in seriously ill patients: geographic patterns, epidemiological features, and trends in the SENTRY Antimicrobial Surveillance Program (1997\u20131999)","volume":"32","author":"Gales AC","year":"2001","unstructured":"Gales AC, Jones RN, Forward KR, Li\u00f1ares J, Sader HS, Verhoef J. Emerging importance of multidrug-resistant Acinetobacter species and Stenotrophomonas maltophilia as pathogens in seriously ill patients: geographic patterns, epidemiological features, and trends in the SENTRY Antimicrobial Surveillance Program (1997\u20131999). Clin Infect Dis 2001; 32(Suppl 2): S104\u2013S113. https:\/\/doi.org\/10.1086\/320183."},{"issue":"Suppl 1","key":"B23","series-title":"Open Forum Infect Dis","first-page":"S34","article-title":"Antimicrobial Susceptibility of Acinetobacter calcoaceticus-Acinetobacter baumannii complex and Stenotrophomonas maltophilia Clinical Isolates: results from the SENTRY Antimicrobial Surveillance Program (1997\u20132016)","volume":"6","author":"Gales AC","year":"2019","unstructured":"Gales AC, Seifert H, Gur D, Castanheira M, Jones RN, Sader HS. Antimicrobial Susceptibility of Acinetobacter calcoaceticus-Acinetobacter baumannii complex and Stenotrophomonas maltophilia Clinical Isolates: results from the SENTRY Antimicrobial Surveillance Program (1997\u20132016). Open Forum Infect Dis 2019; 6(Suppl 1): S34\u2013S46. https:\/\/doi.org\/10.1093\/ofid\/ofy293."},{"key":"B24","series-title":"J Glob Antimicrob Resist","first-page":"282","article-title":"Real-world, multicentre evaluation of the incidence and risk factors for non-susceptible Stenotrophomonas maltophilia isolates","volume":"28","author":"Jones BM","year":"2022","unstructured":"Jones BM, Wagner JL, Chastain DB, Bookstaver PB, Stover K, Lin J, et al. Real-world, multicentre evaluation of the incidence and risk factors for non-susceptible Stenotrophomonas maltophilia isolates. J Glob Antimicrob Resist 2022; 28: 282\u2013287. https:\/\/doi.org\/10.1016\/j.jgar.2022.02.001."},{"issue":"3","key":"B25","series-title":"Af J Clin Exp Micro","first-page":"158","article-title":"Association of sul genes and class 1 integron with trimethoprim sulfamethoxazole resistance in Stenotrophomonas maltophilia clinical isolates in Zagazig University, Egypt","volume":"17","author":"Morsi SS","year":"2016","unstructured":"Morsi SS, Sharaf HE, Gerges MA. Association of sul genes and class 1 integron with trimethoprim sulfamethoxazole resistance in Stenotrophomonas maltophilia clinical isolates in Zagazig University, Egypt. Af J Clin Exp Micro 2016; 17(3): 158\u2013165. https:\/\/doi.org\/10.4314\/ajcem.v17i3.1."},{"issue":"3","key":"B26","series-title":"Ortadogu Med J","first-page":"113","article-title":"Antimicrobial resistance of Stenotrophomonas maltophilia isolated from various clinical specimens","volume":"9","author":"\u015een P","year":"2017","unstructured":"\u015een P, Yula E, Er H, G\u00fcng\u00f6r S, \u00d6zdemir R, Baran N, et al. Antimicrobial resistance of Stenotrophomonas maltophilia isolated from various clinical specimens. Ortadogu Med J 2017; 9(3): 113\u2013117. https:\/\/doi.org\/10.21601\/ortadogutipdergisi.265431."},{"issue":"1","key":"B27","series-title":"ANKEM J","first-page":"16","article-title":"Antimicrobial resistance in clinical strains of Stenotrophomonas maltophilia: a 10-year surveillance","volume":"36","author":"Bilgin M","year":"2022","unstructured":"Bilgin M, \u0130\u015fler H, Ba\u015fbulut E, Y\u0131lmaz EM. Antimicrobial resistance in clinical strains of Stenotrophomonas maltophilia: a 10-year surveillance. ANKEM J 2022; 36(1): 16\u201322. https:\/\/doi.org\/10.54962\/ankemderg.1107833."},{"issue":"7","key":"B28","series-title":"J Med Microbiol","first-page":"992","article-title":"Stenotrophomonas maltophilia isolated from patients exposed to invasive devices in a university hospital in Argentina: molecular typing, susceptibility and detection of potential virulence factors","volume":"67","author":"Alcaraz E","year":"2018","unstructured":"Alcaraz E, Garcia C, Papalia M, Vay C, Friedman L, Passerini de Rossi B. Stenotrophomonas maltophilia isolated from patients exposed to invasive devices in a university hospital in Argentina: molecular typing, susceptibility and detection of potential virulence factors. J Med Microbiol 2018; 67(7): 992\u20131002. https:\/\/doi.org\/10.1099\/jmm.0.000764."},{"issue":"1","key":"B29","series-title":"BMC Res Notes","first-page":"151","article-title":"Antibiotic resistance, biofilm formation, and biofilm-associated genes among Stenotrophomonas maltophilia clinical isolates","volume":"14","author":"Bostanghadiri N","year":"2021","unstructured":"Bostanghadiri N, Ardebili A, Ghalavand Z, Teymouri S, Mirzarazi M, Goudarzi M, et al. Antibiotic resistance, biofilm formation, and biofilm-associated genes among Stenotrophomonas maltophilia clinical isolates. BMC Res Notes 2021; 14 (1): 151. https:\/\/doi.org\/10.1186\/s13104-021-05567-y."},{"issue":"2","key":"B30","series-title":"Dicle Med J","first-page":"237","article-title":"The distribution and antimicrobial susceptibility of Stenotrophomonas maltophilia strains isolated from clinical samples","volume":"43","author":"Kandemir \u0130","year":"2016","unstructured":"Kandemir \u0130, \u00d6zcan N, Alanbayi \u00dc, Bozda\u011f H, Akpolat N, G\u00fcl K. The distribution and antimicrobial susceptibility of Stenotrophomonas maltophilia strains isolated from clinical samples. Dicle Med J 2016; 43(2): 237\u2013240. https:\/\/doi.org\/10.5798\/diclemedj.0921.2016.02.0673."},{"issue":"4","key":"B31","series-title":"Int J Antimicrob Agents","first-page":"328","article-title":"Antimicrobial susceptibility of Gram-negative organisms isolated from patients hospitalised with pneumonia in US and European hospitals: results from the SENTRY antimicrobial Surveillance Program, 2009-2012","volume":"43","author":"Sader HS","year":"2014","unstructured":"Sader HS, Farrell DJ, Flamm RK, Jones RN. Antimicrobial susceptibility of Gram-negative organisms isolated from patients hospitalised with pneumonia in US and European hospitals: results from the SENTRY antimicrobial Surveillance Program, 2009-2012. Int J Antimicrob Agents 2014; 43(4): 328\u2013334. https:\/\/doi.org\/10.1016\/j.ijantimicag.2014.01.007."},{"issue":"3","key":"B32","series-title":"JAC Antimicrob Resist","article-title":"Frequency of occurrence and antimicrobial susceptibility of bacteria isolated from respiratory samples of patients hospitalized with pneumonia in Western Europe, Eastern Europe and the USA: results from the SENTRY Antimicrobial Surveillance Program (2016\u201319)","volume":"3","author":"Sader HS","year":"2021","unstructured":"Sader HS, Streit JM, Carvalhaes CG, Huband MD, Shortridge D, Mendes RE, et al. Frequency of occurrence and antimicrobial susceptibility of bacteria isolated from respiratory samples of patients hospitalized with pneumonia in Western Europe, Eastern Europe and the USA: results from the SENTRY Antimicrobial Surveillance Program (2016\u201319). JAC Antimicrob Resist 2021; 3(3): dlab117. https:\/\/doi.org\/10.1093\/jacamr\/dlab117."},{"issue":"1","key":"B33","series-title":"ANKEM J","first-page":"27","article-title":"Antibiotic resistance of Stenotrophomonas maltophilia strains isolated from blood cultures","volume":"25","author":"T\u00fcrk Da\u011f\u0131 H","year":"2011","unstructured":"T\u00fcrk Da\u011f\u0131 H, Arslan U, Tuncer \u0130. Antibiotic resistance of Stenotrophomonas maltophilia strains isolated from blood cultures. ANKEM J 2011; 25(1): 27\u201330. https:\/\/doi.org\/10.5222\/ankem.2011.27."},{"issue":"1","key":"B34","series-title":"Mikrobiyol Bul","first-page":"35","article-title":"Investigation of the presence of class 1, 2, 3 integrons and their relationships with antibiotic resistance in clinical Stenotrophomonas maltophilia isolates","volume":"49","author":"Usta E","year":"2015","unstructured":"Usta E, Ero\u011flu C, Yan\u0131k K, Karada\u011f A, G\u00fcney AK, G\u00fcnayd\u0131n M. Investigation of the presence of class 1, 2, 3 integrons and their relationships with antibiotic resistance in clinical Stenotrophomonas maltophilia isolates. Mikrobiyol Bul 2015; 49(1): 35\u201346. https:\/\/doi.org\/10.5578\/mb.8459."},{"issue":"Suppl 1","key":"B35","series-title":"J Antimicrob Chemother","first-page":"i7","article-title":"Antimicrobial susceptibility of 22746 pathogens from Canadian hospitals: results of the CANWARD 2007\u201311 study","volume":"68","author":"Zhanel GG","year":"2013","unstructured":"Zhanel GG, Adam HJ, Baxter MR, Fuller J, Nicho KA, Denisuik AJ, et al. Antimicrobial susceptibility of 22746 pathogens from Canadian hospitals: results of the CANWARD 2007\u201311 study. J Antimicrob Chemother 2013; 68(Suppl 1): i7\u2013i22. https:\/\/doi.org\/10.1093\/jac\/dkt022."},{"key":"B36","series-title":"Front Microbiol","first-page":"658","article-title":"Antibiotic resistance in the opportunistic pathogen Stenotrophomonas maltophilia","volume":"6","author":"S\u00e1nchez MB","year":"2015","unstructured":"S\u00e1nchez MB. Antibiotic resistance in the opportunistic pathogen Stenotrophomonas maltophilia. Front Microbiol 2015; 6: 658. https:\/\/doi.org\/10.3389\/fmicb.2015.00658."},{"issue":"2","key":"B37","series-title":"Microbiol Spectr","first-page":"MDNA3","article-title":"The Integron: adaptation on demand","volume":"3","author":"Escudero JA","year":"2015","unstructured":"Escudero JA, Loot C, Nivina A, Mazel D. The Integron: adaptation on demand. Microbiol Spectr 2015; 3(2): MDNA3\u20132014. https:\/\/doi.org\/10.1128\/microbiolspec.MDNA3-0019-2014."},{"issue":"4","key":"B38","series-title":"Microb Drug Resist","first-page":"380","article-title":"Distribution of class 1 integrons, sul1 and sul2 genes among clinical \u0131solates of Stenotrophomonas maltophilia from a Tertiary Care Hospital in North India","volume":"21","author":"Kaur P","year":"2015","unstructured":"Kaur P, Gautam V, Tewari R. Distribution of class 1 integrons, sul1 and sul2 genes among clinical \u0131solates of Stenotrophomonas maltophilia from a Tertiary Care Hospital in North India. Microb Drug Resist 2015; 21(4): 380\u2013385. https:\/\/doi.org\/10.1089\/mdr.2014.0176."},{"key":"B39","series-title":"New Microbes New Infect","article-title":"Prevalence of resistance genes and antibiotic resistance profile among Stenotrophomonas maltophilia isolates from hospitalized patients in Iran","volume":"44","author":"Baseri Z","year":"2021","unstructured":"Baseri Z, Dehghan A, Yaghoubi S, Razavi S. Prevalence of resistance genes and antibiotic resistance profile among Stenotrophomonas maltophilia isolates from hospitalized patients in Iran. New Microbes New Infect 2021; 44: 100943. https:\/\/doi.org\/10.1016\/j.nmni.2021.100943."},{"key":"B40","series-title":"Acta Microbiol Immunol Hung","first-page":"56","article-title":"Prevalence of trimethoprim\/sulfamethoxazole resistance genes among Stenotrophomonas maltophilia clinical isolates in Egypt","volume":"69","author":"Elsheredy A","year":"2022","unstructured":"Elsheredy A, Elsheikh A, Ghazal A, Shawky S. Prevalence of trimethoprim\/sulfamethoxazole resistance genes among Stenotrophomonas maltophilia clinical isolates in Egypt. Acta Microbiol Immunol Hung 2022; 69: 56\u201360. https:\/\/doi.org\/10.1556\/030.2021.01568."}],"container-title":["Acta Microbiologica et Immunologica Hungarica"],"original-title":[],"link":[{"URL":"https:\/\/akjournals.com\/view\/journals\/030\/72\/2\/article-p139.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/akjournals.com\/downloadpdf\/journals\/030\/72\/2\/article-p139.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/akjournals.com\/downloadpdf\/journals\/030\/72\/2\/article-p139.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,20]],"date-time":"2025-06-20T10:21:23Z","timestamp":1750414883000},"score":1,"resource":{"primary":{"URL":"https:\/\/akjournals.com\/view\/journals\/030\/72\/2\/article-p139.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,20]]},"references-count":40,"journal-issue":{"issue":"2"},"URL":"https:\/\/doi.org\/10.1556\/030.2025.02582","relation":{},"ISSN":["1217-8950","1588-2640"],"issn-type":[{"value":"1217-8950","type":"print"},{"value":"1588-2640","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,20]]}}}